Education
About Us
Working with TipRanks
Follow Us
InDex Pharmaceuticals Holding AB (DE:1NP1)
:1NP1
1NP1 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.72 - €7.10
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€280.24M
Enterprise Value€2.80B
Total Cash (Recent Filing)kr428.45M
Total Debt (Recent Filing)kr1.28M
Price to Earnings (P/E)0.3
Beta8.85
Next Earnings
May 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)13.55
Shares Outstanding78,066,410
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)316358.91
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
1NP1 FAQ
What was InDex Pharmaceuticals Holding AB’s price range in the past 12 months?
InDex Pharmaceuticals Holding AB lowest stock price was €0.72 and its highest was €7.10 in the past 12 months.
What is InDex Pharmaceuticals Holding AB’s market cap?
InDex Pharmaceuticals Holding AB’s market cap is €280.24M.
When is InDex Pharmaceuticals Holding AB’s upcoming earnings report date?
InDex Pharmaceuticals Holding AB’s upcoming earnings report date is May 07, 2025 which is in 25 days.
How were InDex Pharmaceuticals Holding AB’s earnings last quarter?
InDex Pharmaceuticals Holding AB released its earnings results on Jan 22, 2025. The company reported -€0.075 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.075.
Is InDex Pharmaceuticals Holding AB overvalued?
According to Wall Street analysts InDex Pharmaceuticals Holding AB’s price is currently Overvalued.
Does InDex Pharmaceuticals Holding AB pay dividends?
InDex Pharmaceuticals Holding AB does not currently pay dividends.
What is InDex Pharmaceuticals Holding AB’s EPS estimate?
InDex Pharmaceuticals Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InDex Pharmaceuticals Holding AB have?
InDex Pharmaceuticals Holding AB has 78,066,410 shares outstanding.
What happened to InDex Pharmaceuticals Holding AB’s price movement after its last earnings report?
InDex Pharmaceuticals Holding AB reported an EPS of -€0.075 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.244%.
Which hedge fund is a major shareholder of InDex Pharmaceuticals Holding AB?
Currently, no hedge funds are holding shares in DE:1NP1
---
Company Description
InDex Pharmaceuticals Holding AB
InDex Pharmaceuticals Holding AB is a pharmaceutical development company focusing on immunological diseases where there is an unmet medical need for new treatment options. Its portfolio includes cobitolimod and colitis.
---
Technical Analysis
Hansa Biopharma AB
―
BioInvent International AB
―
SynAct Pharma AB
―
Vicore Pharma Holding AB
―
Xspray Pharma AB
―
---